GLGuoli Lin

Guoli Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guoli Lin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Caizhi Dai

    Affiliated Hospital of Putian University

    7 shared publications
  • Kaizu Xu

    Department of Cardiology, The Affiliated Hospital of Putian University Putian University Fujian China

    4 shared publications
  • Meifang Wu

    Department of Cardiology, The Affiliated Hospital of Putian University, Putian University, Putian, China

    3 shared publications
  • Wen Chen

    Department of Cardiology, The Affiliated Hospital of Putian University, Putian University, Putian, China

    3 shared publications
  • Kaizu Xu

    Department of Cardiology, School of Clinical Medicine, Fujian Medical University, Affiliated Hospital of Putian University, Putian, China

    2 shared publications
  • Xiaomin Chen

    Affiliated Hospital of Putian University

    2 shared publications

Latest Publications

  • Open Access

    Predictive value of combined estimated plasma volume status and neutrophil-to-lymphocyte ratio for cardiovascular mortality in patients with acute myocardial infarction with heart failure

    by Caizhi Dai, Xiaomin Chen, Xiuting Chen, Guoli Lin

    Objective: Estimated plasma volume status (ePVS) and neutrophil-to-lymphocyte ratio (NLR) are novel biomarkers reflecting hemodynamic load and systemic inflammatory immune status, respectively. This study aimed to explore the prognostic value of combined ePVS and NLR for cardiovascular mortality in patients with heart failure (HF) complicating acute myocardial infarction (AMI). Methods: This retrospective observational study consecutively enrolled patients diagnosed with AMI complicated by HF at Putian University Affiliated Hospital from January 2020 to June 2024. Admission hemoglobin and hematocrit levels were used to calculate ePVS, while routine blood test parameters were applied to determine NLR. The primary endpoint was cardiovascular mortality within two years after AMI. Cox proportional hazards regression models were constructed to analyze the associations of ePVS and NLR with clinical endpoints. The predictive efficacy of single and combined ePVS and NLR was comprehensively evaluated using the area under the receiver operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: A total of 2046 patients were ultimately included. During a mean follow-up of 819 days, endpoint events occurred in 14.90% of the study population. Univariate Cox regression analysis demonstrated that ePVS served as a strong risk factor for cardiovascular mortality (HR = 1.571, 95% CI: 1.502–1.642, P < 0.001). After adjusting for age, diabetes mellitus, hypertension, atrial fibrillation, and NLR, both ePVS (HR = 1.436, 95% CI: 1.370–1.505, P < 0.001) and NLR (HR = 1.330, 95% CI: 1.258–1.406, P < 0.001) remained independent predictors of cardiovascular mortality. The combined predictive model integrating ePVS and NLR exhibited significantly superior predictive performance compared with either biomarker alone (AUC: 0.794 for ePVS vs. 0.891 for ePVS + NLR, P < 0.001). Both NRI and IDI analyses further verified the significant improvement in predictive accuracy of the combined model (all P < 0.01). Conclusion: ePVS and NLR represent valuable prognostic biomarkers for cardiovascular mortality in AMI patients. The combination of ePVS and NLR significantly improves predictive performance and facilitates precise risk stratification.

  • Open Access

    The AHEAD-NLR score: a novel inflammatory-comorbidity integrated tool for predicting long-term mortality in patients with heart failure after acute myocardial infarction

    by Guoli Lin, Caizhi Dai, Wen Chen

    The AHEAD score (Atrial fibrillation, Hemoglobin, Elderly age, Abnormal renal function, and Diabetes) has proven valuable for risk stratification in acute heart failure. However, its prognostic utility specifically in the distinct and high-risk population of patients who develop heart failure after an acute myocardial infarction (AMI) remains to be clarified. Current risk assessment tools in this setting often underrepresent the significant role of systemic inflammation, a key driver of adverse remodeling and poor outcomes post-AMI. To address this gap, we incorporated the Neutrophil-to-lymphocyte ratio (NLR), a robust and readily available marker of inflammatory response. The modified AHEAD-NLR score aims to integrate established clinical risk factors with inflammatory activity, thereby addressing a critical limitation of prior tools and potentially offering a more comprehensive prognostic model. A total of 840 patients with heart failure after AMI were enrolled in this study (age 62.55 ± 11.89 years, 81.90% men), with a median follow-up duration of 954 days. The predictive efficacy of the AHEAD score for all-cause mortality was evaluated using Cox regression analysis. The mean AHEAD score of study was 1.05 ± 1.04. After adjusting for age, gender, red cell distribution width (RDW), uric acid, serum potassium, D-dimer, Neutrophil-to-lymphocyte ratio (NLR), and Left ventricular ejection fraction(LVEF), the AHEAD score was still significantly associated with an increased risk of all-cause mortality (hazard ratio and 95% confidence interval: 1.270, 1.019–1.582). In addition, when we constructed a new score, AHEAD-NLR, by incorporating the NLR (≥ 8.16) into the AHEAD score, the net reclassification improvement for predicting all-cause mortality was increased by 19.9%. AHEAD score is an independent predictor of all-cause mortality in patients with HF after AMI. AHEAD-NLR score, which integrates clinical risk factors and inflammatory status, further optimizes risk stratification, offering a more comprehensive prognostic tool for this high-risk population.


  • Open Access

    Systemic inflammatory regulators and heart failure: A bidirectional 2-sample Mendelian randomization study

    by Guoli Mm Lin, Caizhi Mm Dai

    The causal relationship between systemic inflammation and heart failure (HF) remains controversial, with unresolved questions about whether inflammatory dysregulation is a driver or consequence of HF pathogenesis. To evaluate bidirectional causal associations between systemic inflammatory regulators and HF using Mendelian randomization (MR). The genetic association with HF came from the largest and most recent genome-wide association study (cases and proxy cases: 47,309; Control: 9,30,014), as well as inflammatory regulators from the nearest cytokine genome-wide association study. Estimates were obtained by inverse variance weighting using the sensitivity analysis of MR-Egger, weighted median and MR-PRESSO. Three of the 41 systemic inflammatory regulators were associated with the risk of HF, macrophage inflammatory protein-1β and regulated on activation, normal T cell expressed and secreted were positively associated with HF, and Macrophage migration inhibitory factor was negatively associated with HF. In contrast, HF was not associated with 41 systemic inflammatory regulators, and the results of the validation analysis were consistent. This MR study identifies macrophage inflammatory protein-1β and regulated on activation, normal T cell expressed and secreted as causal risk factors and migration inhibitory factor as a protective factor for HF, implicating these regulators as upstream therapeutic targets. Reverse analyses found no evidence of HF-induced inflammatory changes, supporting the unidirectional causality model.

  • Open Access

    Predictive value of serum iron on heart failure in patients with acute ST‐segment elevation myocardial infarction

    by Wen Chen, Guoli Lin, Caizhi Dai, Kaizu Xu

    Background: In clinical practice, heart failure often occurs after acute myocardial infarction, and a new biomarker for its early prediction is urgently needed. The aim of this study was to investigate the relationship between serum iron and heart failure after acute ST‐segment elevation myocardial infarction (STEMI).Methods: A total of 41 patients with heart failure after STEMI and 31 controls were included in the study. The demographic variables and baseline clinical characteristics of both groups were analyzed.Results: There were no significant differences between patients with heart failure and controls in terms of demographic characteristics. There were significant differences in terms of serum iron, N terminal pro‐B‐type natriuretic peptide levels, left atrial diameter, and left ventricular ejection fraction. Binary logistic regression analyses demonstrated that serum iron (odds ratio [OR]: 0.804, 95% confidence interval [CI]: 0.699–0.924) and Tn‐I (OR: 1.072, 95% CI: 1.011–1.137) were independent predictors for heart failure (p < .05, respectively). Receiver operating characteristic analysis showed that the area under the curve for serum iron was 0.808 (95% CI: 0.707–0.908, p < .01). The best cutoff value of serum iron was 11.87 μmol/L (sensitivity: 87.1%; specificity: 68.3%).Conclusions: Patients with heart failure after STEMI have lower serum iron levels than patients without heart failure after STEMI. Serum iron levels are a risk factor for heart failure after STEMI.


  • Open Access

    Effect of estimated plasma volume status and left atrial diameter on prognosis of patients with acute heart failure

    by Xiaomin Chen, Guoli Lin, Caizhi Dai, Kaizu Xu

    Objective: Acute heart failure (AHF) is a frequent cardiovascular emergency presenting with high mortality as well as readmission rates. The aim was to investigate the predictive value of estimated plasma volume status (ePVs) and left atrial diameter (LAD) for the prognosis of patients with AHF.Methods: Clinical profiles were collected from 259 cases of AHF patients at the Affiliated Hospital of Putian University between September 2019 and October 2021.Results: Six patients lost follow-up, resulting in 253 patients enrolled. Cardiogenic death and heart failure readmission during follow-up were defined as major cardiovascular events (MACE) group, other patients were defined as Non-MACE group. Apart from age, no significant differences were found between the two groups in demographics and comorbidities. The comparison between the two groups was statistically significant in terms of ePVs, LAD, and N-terminal-pro B-type natriuretic peptide (Nt-pro-BNP). On binary logistic regression analysis, ePVs (OR = 2.061, 95% CI 1.322∼3.214, P = 0.001), LAD (OR = 1.054, 95% CI 1.012∼1.098, P = 0.011), and Nt-pro-bnp (OR = 1.006, 95% CI 1.003∼1.010, P = 0.036) as predicting factors for MACE. Kaplan-Meier analysis indicated that the risk for cardiogenic death increasing with ePVs (p < 0.05).Conclusion: Estimated plasma volume status and LADs have some predictive value in assessing cardiogenic death and heart failure readmission in patients with AHF.


  • The Value of Sacubitril/Valsartan in Acute Anterior Wall ST-Segment Elevation Myocardial Infarction before Emergency Percutaneous Coronary Intervention

    by Guoli Lin, Wen Chen, Meifang Wu, Caizhi Dai, Kaizu Xu

    Background: Many patients present with heart failure with reduced ejection fraction (HFrEF) after acute anterior wall ST-segment elevation myocardial infarction (STEMI). The purpose of this study was to evaluate the effect of preprocedural sacubitril/valsartan on N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) and left ventricular ejection fraction (LVEF) in patients with acute anterior STEMI undergoing percutaneous coronary intervention (PCI). Methods: We enrolled patients with acute anterior wall STEMI who underwent emergency PCI at The Affiliated Hospital of Putian University from January 2019 to January 2021. Prior to PCI, patients were randomized to receive sacubitril/valsartan or valsartan. Nonculprit lesion vessels that require PCI were excluded. The primary endpoints included changes in NT-pro-BNP, LVEF, and rehospitalization for heart failure (HF) during the follow-up period. Results: Out of 109 patients who were randomized, 55 were assigned to receive sacubitril/valsartan and 54 were assigned to receive valsartan. The decrease in NT-pro-BNP concentrations and the increase in LVEF were significantly greater in the sacubitril/valsartan group than in the valsartan group. Conclusions: In patients with acute anterior wall STEMI undergoing emergency PCI, preprocedural initiation of sacubitril/valsartan therapy increased LVEF and lower NT-pro-BNP concentrations compared with valsartan therapy.


  • Open Access

    Predictive Value of Red Blood Cell Distribution Width and Atrial Diameter in Paroxysmal Atrial Fibrillation: A Cross-Sectional Study

    by Guoli Lin, Caizhi Dai, Kaizu Xu, Meifang Wu

    Atrial fibrillation (AF) is the most common arrhythmia and is associated with deleterious consequences. In addition to worsening a patient’s quality of life, AF is associated with stroke, heart failure, and increased mortality. Red blood cell distribution width (RDW) has been associated with an increased risk of death and adverse cardiovascular outcomes, while left atrial enlargement has been linked to atrial fibrillation (AF). However, the relationship among RDW, atrial diameter (AD), and paroxysmal AF is uncertain. The aim of this study was to investigate the relationship among RDW, atrial diameter, and paroxysmal AF. A total of 22 patients with paroxysmal AF and 100 patients with non-AF were included in the study. The demographic variables and baseline clinical characteristics of both groups were analyzed. The demographics and comorbidities were comparable between the paroxysmal AF and control groups, except for BMI (body mass index). RDW, high-sensitivity C-reactive protein (hs-CRP) levels, NT-pro-BNP levels, MPV/PLT (mean platelet volume/total platelet count), LAD, RAD, and CHA2DS2-VASc score were higher in the paroxysmal AF group versus the control group (P2DS2-VASc score (OR: 1.645, 95% CI: 1.042~2.597) were independent predictors for paroxysmal AF (P<0.05, respectively). The ROC analysis showed that the area under the curve for LAD was 0.692, the area under the curve for RAD was 0.566, the area under the curve for RDW was 0.811, and the area under the curve for MPV/PLT was 0.671. LAD, RDW, and MPV/PLT were associated with paroxysmal AF.


  • Retracted
    Open Access

    The Significance of Apolipoprotein-A in the Long-Term Death of Patients with STEMI

    by Guoli Lin, Wen Chen, Caizhi Dai, Kaizu Xu

    Objective. To analyze apolipoprotein-A for its predictive value for long-term death in individuals suffering from acute ST-segment elevation myocardial infarction following percutaneous coronary intervention. Methods. We selected patients suffering from acute ST-segment elevation myocardial infarction who underwent emergency PCI at the Affiliated Hospital of Putian University from January 2017 to August 2019. The patients were divided into a high-Apo-A group and low-Apo-A group, and we observed all-cause deaths of patients in the 2 groups within 2 years. Results. The ROC curve analysis indicated the best critical value for predicting 2-year mortality as 0.8150 (area under the curve was 0.626, sensitivity 75.1, and specificity 51.9). There was no statistical difference among the two groups in gender, age, lesion vessel, and comorbidities. The two groups had statistically significant differences in apolipoprotein-B/A, high-density lipoprotein, apolipoprotein-A, and hypersensitivity C-reactive protein. Correlation analysis showed a significant negative correlation between apolipoprotein-A and hypersensitive C-reactive protein. The results of the 24-month analysis indicated the incidence of all-cause mortality as higher in the low-Apo-A group, and KaplanMeier survival analysis showed the same trend. Conclusion. Apolipoprotein-A can predict the potential for long-term mortality among individuals having acute ST-segment elevation myocardial infarction.


  • Open Access

    Predictive value of neutrophil to lymphocyte ratio and red cell distribution width on death for ST segment elevation myocardial infarction

    by Guoli Lin, Caizhi Dai, Kaizu Xu, Meifang Wu

    There are many clinical scoring criteria for predicting the risk of death in patients with acute ST-segment elevation myocardial infarction (STEMI), but most of the indicators are complex to calculate and are not suitable for use in primary hospitals. Neutrophil to lymphocyte ratio (NLR) and red cell distribution width (RDW) are blood routine indicators that are easy to obtain and may help primary hospitals to evaluate the risk of death in patients with STEMI. Our aim was to explore the predictive value of NLR combined with RDW in the long-term prognosis of patients with STEMI after emergency percutaneous coronary intervention (PCI). A total of 181 patients with STEMI who underwent emergency PCI in the Affiliated Hospital of Pu-tian University from January 2017 to August 2018 were selected. Clinical profile, prognosis of all patients were collected. P value < 0.05 was considered significant. In all patients, cardiovascular death during the follow-up period was defined as cardiovascular death group, and surviving during the follow-up period was defined as survival group. There were no significant differences in demography and comorbidities between the two groups. The differences between the two groups in NLR, RDW, C-reactive protein, N-terminal-pro B type natriuretic peptide were statistically significant (P < 0.01). Binary logistic regression analysis showed that NLR (OR = 1.122, 95% CI 1.041 ~ 1.210, P = 0.003) and RDW (OR = 1.288, 95% CI 1.126 ~ 1.472, P = 0.0005) were important predictors of mortality in patients with STEMI (P < 0.05). Kaplan–Meier analysis showed that as the NLR increased, the risk of death increased (P < 0.001). In conclusion, NLR and RDW are independent predictors of cardiovascular death in patients with STEMI, and they have a certain predictive value.